The ICD10 code news is interesting and I’m unsure how to interpret it. On one hand, Leronlimab doesn’t simply get on this list, but on the other hand, the FDA still has to give leronlimab EUA or full approval. The rise in SP today is in no doubt related to this news.

Regardless, let’s hope the CC isn't a nothingburger or we will lose some of these gains.